↓ Skip to main content

Cochrane Database of Systematic Reviews

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

blogs
1 blog
twitter
12 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
42 Mendeley
Title
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Published in
Cochrane database of systematic reviews, August 2022
DOI 10.1002/14651858.cd014383.pub2
Pubmed ID
Authors

Irene Bighelli, Alessandro Rodolico, Spyridon Siafis, Myrto T Samara, Wulf-Peter Hansen, Salvatore Salomone, Eugenio Aguglia, Pierfelice Cutrufelli, Ingrid Bauer, Lio Baeckers, Stefan Leucht

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 12%
Other 3 7%
Student > Ph. D. Student 3 7%
Student > Bachelor 2 5%
Lecturer > Senior Lecturer 1 2%
Other 3 7%
Unknown 25 60%
Readers by discipline Count As %
Medicine and Dentistry 6 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Nursing and Health Professions 2 5%
Psychology 1 2%
Sports and Recreations 1 2%
Other 5 12%
Unknown 25 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2023.
All research outputs
#2,666,593
of 25,462,162 outputs
Outputs from Cochrane database of systematic reviews
#5,345
of 12,766 outputs
Outputs of similar age
#55,839
of 430,551 outputs
Outputs of similar age from Cochrane database of systematic reviews
#72
of 96 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,766 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.5. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.